Dr Douglas Jay Rowles, MD - Medicare Orthopedic Surgery in Oklahoma City, OK

Dr Douglas Jay Rowles, MD is a medicare enrolled "Orthopaedic Surgery - Sports Medicine" physician in Oklahoma City, Oklahoma. He graduated from medical school in 1995 and has 29 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Ou Health Partners Inc and his current practice location is 920 Stanton L Young Blvd, Suite Wp 1380, Oklahoma City, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (405) 271-4426.

Dr Douglas Jay Rowles is licensed to practice in Oklahoma (license number 30905) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1629041801.

Contact Information

Dr Douglas Jay Rowles, MD
920 Stanton L Young Blvd, Suite Wp 1380,
Oklahoma City, OK 73104-5036
(405) 271-4426
(405) 271-3074



Physician's Profile

Full NameDr Douglas Jay Rowles
GenderMale
SpecialityOrthopedic Surgery
Experience29 Years
Location920 Stanton L Young Blvd, Oklahoma City, Oklahoma
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Douglas Jay Rowles graduated from medical school in 1995
  NPI Data:
  • NPI Number: 1629041801
  • Provider Enumeration Date: 02/09/2006
  • Last Update Date: 04/06/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 7214901685
  • Enrollment ID: I20150421000442

Medical Identifiers

Medical identifiers for Dr Douglas Jay Rowles such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629041801NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207XX0005XOrthopaedic Surgery - Sports Medicine 30905 (Oklahoma)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
O U Medical CenterOklahoma city, OKHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Ou Health Partners Inc5991105876779

News Archive

Spherix Phase 2 diabetes clinical trial determines minimum D-tagatose dose capable of reducing HbA1c

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested

China, U.K. form global health partnership

"The Chinese and British governments are cooperating on a program to improve global health policy for developing countries, with the launch in Beijing on January 16 of a new U.K.-China partnership," China Daily reports.

Lexicon to receive funding for LX4211 Phase 2 trial in type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

New MHA report calls on the country to address mental health issues

Our country is failing those in need of mental health services, according to a new report released by Mental Health America, the nation's leading community-based mental health advocacy organization. MHA for the first time has provided overall rankings for all 50 states and the District of Columbia on mental health status and access, and calls on the country to address mental health before Stage 4.

Experts in camouflage breaking can accurately detect target in less than a second,

After looking for just one-twentieth of a second, experts in camouflage breaking can accurately detect not only that something is hidden in a scene, but precisely identify the camouflaged target, a skill set that can mean the difference between life and death in warfare and the wild, investigators report.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Douglas Jay Rowles allows following entities to bill medicare on his behalf.
Entity NameBoard Of Regents Of The University Of Oklahoma - Ou Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801869250
PECOS PAC ID: 2860304334
Enrollment ID: O20031103000607

News Archive

Spherix Phase 2 diabetes clinical trial determines minimum D-tagatose dose capable of reducing HbA1c

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested

China, U.K. form global health partnership

"The Chinese and British governments are cooperating on a program to improve global health policy for developing countries, with the launch in Beijing on January 16 of a new U.K.-China partnership," China Daily reports.

Lexicon to receive funding for LX4211 Phase 2 trial in type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

New MHA report calls on the country to address mental health issues

Our country is failing those in need of mental health services, according to a new report released by Mental Health America, the nation's leading community-based mental health advocacy organization. MHA for the first time has provided overall rankings for all 50 states and the District of Columbia on mental health status and access, and calls on the country to address mental health before Stage 4.

Experts in camouflage breaking can accurately detect target in less than a second,

After looking for just one-twentieth of a second, experts in camouflage breaking can accurately detect not only that something is hidden in a scene, but precisely identify the camouflaged target, a skill set that can mean the difference between life and death in warfare and the wild, investigators report.

Read more Medical News

› Verified 5 days ago

Entity NameOu Health Partners Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528642642
PECOS PAC ID: 5991105876
Enrollment ID: O20210615000618

News Archive

Spherix Phase 2 diabetes clinical trial determines minimum D-tagatose dose capable of reducing HbA1c

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested

China, U.K. form global health partnership

"The Chinese and British governments are cooperating on a program to improve global health policy for developing countries, with the launch in Beijing on January 16 of a new U.K.-China partnership," China Daily reports.

Lexicon to receive funding for LX4211 Phase 2 trial in type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

New MHA report calls on the country to address mental health issues

Our country is failing those in need of mental health services, according to a new report released by Mental Health America, the nation's leading community-based mental health advocacy organization. MHA for the first time has provided overall rankings for all 50 states and the District of Columbia on mental health status and access, and calls on the country to address mental health before Stage 4.

Experts in camouflage breaking can accurately detect target in less than a second,

After looking for just one-twentieth of a second, experts in camouflage breaking can accurately detect not only that something is hidden in a scene, but precisely identify the camouflaged target, a skill set that can mean the difference between life and death in warfare and the wild, investigators report.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Douglas Jay Rowles is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Douglas Jay Rowles, MD
920 Stanton L Young Blvd, Suite Wp 1380,
Oklahoma City, OK 73104-5036

Ph: (405) 271-4426
Dr Douglas Jay Rowles, MD
920 Stanton L Young Blvd, Suite Wp 1380,
Oklahoma City, OK 73104-5036

Ph: (405) 271-4426

News Archive

Spherix Phase 2 diabetes clinical trial determines minimum D-tagatose dose capable of reducing HbA1c

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested

China, U.K. form global health partnership

"The Chinese and British governments are cooperating on a program to improve global health policy for developing countries, with the launch in Beijing on January 16 of a new U.K.-China partnership," China Daily reports.

Lexicon to receive funding for LX4211 Phase 2 trial in type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

New MHA report calls on the country to address mental health issues

Our country is failing those in need of mental health services, according to a new report released by Mental Health America, the nation's leading community-based mental health advocacy organization. MHA for the first time has provided overall rankings for all 50 states and the District of Columbia on mental health status and access, and calls on the country to address mental health before Stage 4.

Experts in camouflage breaking can accurately detect target in less than a second,

After looking for just one-twentieth of a second, experts in camouflage breaking can accurately detect not only that something is hidden in a scene, but precisely identify the camouflaged target, a skill set that can mean the difference between life and death in warfare and the wild, investigators report.

Read more News

› Verified 5 days ago


Orthopaedic Surgery Doctors in Oklahoma City, OK

Dr. Kimberly S Smith, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114
Phone: 405-749-5025    Fax: 405-749-3585
Mr. Nathan E Bradley, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 3301 N.w. 50th St, Oklahoma City, OK 73112
Phone: 405-947-0911    
Thomas Craddock Howard Iii, MD
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 9600 Broadway Ext, Oklahoma City, OK 73114
Phone: 405-230-9412    Fax: 405-230-9157
Richard J Langerman Jr., DO
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 8100 S Walker Ave Bldg A, Oklahoma City, OK 73139
Phone: 405-632-4468    Fax: 405-632-0436
Dr. Rishi Thakral, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 825 Ne 10th St, Oupb 1c, Oklahoma City, OK 73104
Phone: 405-271-2663    Fax: 405-271-6762
Dr. William Austin Doss, DO
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 5401 N Portland Ave # 600, Oklahoma City, OK 73112
Phone: 405-713-9941    
Paul Alan Kammerlocher, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3115 Sw 89th St, Oklahoma City, OK 73159
Phone: 405-486-6900    Fax: 405-486-6839

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.